# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Paul Robeson (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML048-SYN-TD
- Date: 1957-03-12
- Fictional facility: St. Posthumous Health Center
- Fictional author: Theodore Bankole-Ashworth, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Review of results, with psychiatric consultation the same day. **S**

## History of present illness

Mr. Robeson returns three days after his first visit and is seen by Dr. Lindqvist-Adebayo of psychiatry today. His blood tests are normal. He still wakes at three in the morning and cannot get back to sleep, has little appetite, and has spent most of the three days at home. On two of the days he again thought he would be better off dead, without any wish or plan to act; he kept to his safety plan, has put his medicines in a locked box, and has the 988 number in his phone. He has had no alcohol. He asked again who can read his record, and the protections were explained. In the structured interview with Dr. Lindqvist-Adebayo he described a first depression about two years ago, after surgery, which lifted slowly over some months without treatment. Before it he had some weeks of intense, absorbed work, sleeping his usual hours, without elation, irritability, racing thoughts or risky behavior. **S**

| Element | Detail |
|---|---|
| Symptoms | Early waking, poor appetite, low mood and withdrawal unchanged |
| Safety | Passive thoughts of death on two days; no intent or plan; medicines locked |
| Results | Blood count, metabolic panel, calcium, TSH, B12, folate, testosterone and A1c normal; HIV and syphilis tests negative |
| Consultation | Structured interview and bipolar screening with psychiatry today |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Exhausted; poor appetite; weight 98.8 kg |
| Psychiatric | Positive | Low mood, loss of interest, early waking, passive thoughts of death on two days; no hallucinations |
| Neurological | Negative | No headache, weakness or memory complaint |
| Genitourinary | Negative | No urinary symptoms since the prostate surgery |

4 systems reviewed. **S**

## Current medications

- Sertraline 50 mg tablet, one tablet each morning **S**

## Allergies

- No known allergy **S**

## Objective

BP 126/78 mmHg; pulse 74 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 98.8 kg; BMI 27.4 kg/m². All vital signs are synthetic.

No condition-specific results recorded.

## Physical examination

| System | Finding |
|---|---|
| General | Tired, well groomed; weight 98.8 kg; blood pressure 126/78, pulse 74 |
| Psychiatric | Slowed speech and movement; mood 'worn through'; constricted affect; logical thought; no delusions; passive thoughts of death without intent or plan; insight good |
| Neurological | No focal signs; no tremor |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Major depressive disorder, recurrent, severe, without psychotic features** (F33.2). The structured interview confirms a second major depressive episode, severe, without psychotic features. The MDQ is negative (5 of 13 items, not clustered in one period) and the interview finds no past hypomanic or manic episode: the earlier period of intense work had no reduced need for sleep, elation, irritability or risky behavior. The tests exclude thyroid disease, anemia, low B12 or folate, low testosterone, high calcium, diabetes, HIV and syphilis as causes; he takes no medicine that causes depression. His fear of being watched is realistic for a man in his position and is not a psychotic symptom; recording it as paranoia would repeat a documented pattern of misdiagnosis in Black patients. Dr. Lindqvist-Adebayo and I agree on the plan. **S**
   - Sertraline 50 mg each morning from today, rising to 100 mg in two weeks after a nurse's phone check.
   - Behavioral activation weekly with a psychologist he has chosen.
   - Six-week review; sodium then.
   - Watch for any rise in energy with less need for sleep after the antidepressant starts, and call if it happens.
2. **Political persecution and loss of income** (Z60.5). A real and continuing stressor that sustains the depression. **S**
   - Social worker to help with income and costs.
   - Therapy to include coping with the persecution, not only the symptoms.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | PHQ-9 | Baseline and at least monthly during acute treatment (CMID) | Up to date | 22 three days ago, item 9 scored 1 |
| Survey | Structured diagnostic interview | At diagnosis | Completed today | Second major depressive episode, severe, without psychotic features; no past hypomania or mania |
| Survey | Mood Disorder Questionnaire (MDQ) | Once at the initial depression workup (CMID) | Completed today | 5 of 13 items, not in one period and without serious problems: negative |
| Survey | Suicide-risk review (C-SSRS screen since the last visit), safety plan, locked medicines and the 988 Suicide & Crisis Lifeline | Every visit during active treatment | Completed today | Passive thoughts of death on two days; no intent, plan or preparation; medicines locked; 988 in his phone |
| Laboratory | Tests for medical causes of depression | At diagnosis | Up to date | Blood count, metabolic panel, calcium, TSH, B12, folate, morning testosterone and A1c normal three days ago; HIV and syphilis tests negative |
| Survey | Cognitive screen (MoCA) | Baseline, and before and during any course of ECT | Up to date | MoCA 28 three days ago |
| Medication safety | Start of sertraline | At the start, at two weeks and with each dose change | Completed today | 50 mg from today; nausea, sleep change and sexual side effects explained; nurse phone check in two weeks before the increase |
| Laboratory | Sodium (SSRI or SNRI in an older adult) | Baseline, about four to six weeks after starting, and with symptoms | Up to date | 140 mmol/L at baseline; next at six weeks |
| Medication safety | Watch for hypomania or mixed features after starting or changing an antidepressant | Every visit; repeat the MDQ if features emerge | Completed today | Explained what to watch for; none at baseline |
| Referral | Behavioral activation with a psychologist | Weekly for about sixteen sessions | Ordered | First session next week with a psychologist he chose |
| Self-management | Trust, confidentiality and culturally responsive care | Every visit | Completed today | Record protections explained; his account of surveillance recorded as realistic; a therapist of his choosing |
| Referral | Social work for income and costs | At diagnosis and as needed | Referred | First meeting with the social worker next week |
| Referral | Psychiatric consultation | Within days for severe depression with thoughts of death | Completed today | Seen today by Dr. Lindqvist-Adebayo |

## Goal progress

- Response to treatment: PHQ-9 down by at least half from 22. In progress; target 1957-10-05. **S**
- Remission: PHQ-9 below 5. In progress; target 1957-10-05. **S**
- Stay safe: safety plan in place and reviewed at every visit, with no self-harm. In progress; target 1957-10-05. **S**
- Sing again: daily vocal practice and one public engagement a month. In progress; target 1957-10-05. **S**
- Sleep six to seven hours a night. In progress; target 1957-10-05. **S**

## Medication changes

- Started: Sertraline 50 mg tablet, one tablet each morning **S**

## Guideline basis

- APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019), American Psychological Association
- VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022), U.S. Department of Veterans Affairs and Department of Defense
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), U.S. Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge
- Williams DR, et al. Prevalence and distribution of major depressive disorder in African Americans, Caribbean blacks, and non-Hispanic whites: results from the National Survey of American Life. Arch Gen Psychiatry 2007;64(3):305-315 (2007), Archives of General Psychiatry (PubMed 17339519)
- Racial disparities in psychotic disorder diagnosis: A review of empirical literature (2014), World Journal of Psychiatry (PubMed 25540728)

## Follow-up

- Nurse phone call in two weeks before the sertraline increase. Six-week review with the PHQ-9 and sodium. Weekly behavioral activation. Call or text 988 at any time in a crisis. **S**
- Next scheduled visit 1957-04-20: six-week review: minimal response; sertraline increased. **S**
